Facebook
X
LinkedIn
ForwardMarch 24, 2026 MGH Clinical Conversations with MCPAP 2025-2026: Antipsychotics in Youth
A conversation with a Massachusetts Child Psychiatry Access Program (MCPAP)
Psychiatrist or subject matter expert on a variety of behavioral health topics. The goal of MCPAP is to increase access to behavioral health treatment by making child psychiatry services – a scarce resource – available to PCPs across the Commonwealth. Through these conversations we seek to improve clinicians comfort and competency treating mild to moderate behavioral health disorders and address barriers in knowledge. MCPAP hosts a series of nine webinars throughout the year, which usually take place September through June, except December.
Target Audience
This activity is intended for pediatric and family providers.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Develop an understanding of how commonly antipsychotic medications are prescribed
- Familiarity with common side-effects of antipsychotics
- Understand the monitoring schedule and how to manage side-effects that do occur
Additional Information
Massachusetts Child Psychiatry Access Program & Mass General Brigham
Barry Sarvet, MD - Course Director
Child Psychiatrist, Baystate Medical Center;
Chair, Department of Psychiatry,
UMass Chan Medical School – Baystate;
Medical Director, Massachusetts Child Psychiatry Access Program (MCPAP)
Yoshio Kaneko, MD
Staff Psychiatrist, Massachusetts General Hospital
Director, Transitional Age Youth Clinic – Massachusetts General Hospital
Site Director, Massachusetts Child Psychiatry Access Program (MCPAP)
Interim Chief, Child & Adolescent Psychiatry – Newton-Wellesley Hospital
Director, Outpatient Programming – Newton-Wellesley Hospital
Director, Child & Adolescent Consultation & Liaison – Newton-Wellesley Hospital
Instructor in Psychiatry, Harvard Medical School
In support of improving patient care, this activity has been planned and implemented by Mass General Brigham and Massachusetts Child Psychiatry Access Program (MCPAP). Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation